Table 3.
Staging and outcomes | |
---|---|
Stages of AKI# | N (%) |
Stage 1 | 11 (50%) |
Stage 2 | 3 (14%) |
Stage 3 | 8 (36%) |
Median time to peak creatinine in days (Range) | 0 (0–9) |
Median time to resolution of AKI in days (Range)$ | 4 (1–12) |
Patients with residual kidney impairment at the time of discharge (%) | 4/22 (18%) |
Kidney Replacement Therapy | 0 |
Resolution of AKI: eGFR > 100 ml/min/1.73m2.
Stage 1- Serum creatinine 1.5–1.9 times baseline OR > 0.3 mg/dl (> 26.5 μmol/l) increase.
Stage 2- Serum creatinine 2.0–2.9 times baseline.
Stage 3- Serum creatinine 3.0 times baseline OR increase in serum creatinine to > 4.0 mg/dl (> 353.6 μmol/l) OR Initiation of kidney replacement therapy OR, in patients <18 years, decrease in eGFR to <35 ml/min per 1.73 m2.